ES2133537T3 - Extracto de flores de salvia officinalis, procedimiento para su preparacion y su uso. - Google Patents

Extracto de flores de salvia officinalis, procedimiento para su preparacion y su uso.

Info

Publication number
ES2133537T3
ES2133537T3 ES94906217T ES94906217T ES2133537T3 ES 2133537 T3 ES2133537 T3 ES 2133537T3 ES 94906217 T ES94906217 T ES 94906217T ES 94906217 T ES94906217 T ES 94906217T ES 2133537 T3 ES2133537 T3 ES 2133537T3
Authority
ES
Spain
Prior art keywords
pct
extract
salvia officinalis
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94906217T
Other languages
English (en)
Spanish (es)
Inventor
Max Reinhard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heilmittelbetrieb Isernhagen GmbH
Original Assignee
Heilmittelbetrieb Isernhagen GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heilmittelbetrieb Isernhagen GmbH filed Critical Heilmittelbetrieb Isernhagen GmbH
Application granted granted Critical
Publication of ES2133537T3 publication Critical patent/ES2133537T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
ES94906217T 1993-02-10 1994-02-03 Extracto de flores de salvia officinalis, procedimiento para su preparacion y su uso. Expired - Lifetime ES2133537T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4303823A DE4303823C2 (de) 1993-02-10 1993-02-10 Verwendung eines Extraktes aus Blüten von Salvia officinalis bei der Bekämpfung von Durchblutungsstörungen

Publications (1)

Publication Number Publication Date
ES2133537T3 true ES2133537T3 (es) 1999-09-16

Family

ID=6480040

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94906217T Expired - Lifetime ES2133537T3 (es) 1993-02-10 1994-02-03 Extracto de flores de salvia officinalis, procedimiento para su preparacion y su uso.

Country Status (12)

Country Link
US (1) US5660831A (da)
EP (1) EP0683672B1 (da)
JP (1) JP3390443B2 (da)
CN (1) CN1056285C (da)
AT (1) ATE179893T1 (da)
AU (1) AU6001894A (da)
DE (2) DE4303823C2 (da)
DK (1) DK0683672T3 (da)
ES (1) ES2133537T3 (da)
GR (1) GR3030869T3 (da)
HK (1) HK1011937A1 (da)
WO (1) WO1994017814A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0875250A1 (de) * 1997-04-29 1998-11-04 Heilmittelbetrieb Isernhagen GmbH Verwendung eines Extraktes aus Salvia officinalis bei der Bekämpfung der Dupuytren-Kontraktur
EP1002521B1 (de) * 1998-11-19 2002-07-24 Heilmittelbetrieb Isernhagen GmbH Verwendung von Salbeiextrakten erhalten durch Extraktion mit Kohlendioxid als Deodorantien
US6117431A (en) * 1999-12-03 2000-09-12 Pharmline Inc. Method for obtaining an extract from ginkgo biloba leaves
US20020142013A1 (en) * 2001-01-31 2002-10-03 Maes Daniel H. Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function
GB201421479D0 (en) * 2014-12-03 2015-01-14 Phynova Ltd A plant extract and compounds for use in wound healing
CN106318635A (zh) * 2016-08-28 2017-01-11 广西灏源盛世生物科技有限公司 一种快乐鼠尾草精油的提取方法
EP3727414B1 (en) * 2017-12-19 2022-01-26 Altergon S.a. Salvia haenkei extract as an active agent in tissue re-epithelizing and cicatrizing processes
CN114869931A (zh) * 2022-05-09 2022-08-09 浙江欣瑞达康生物医学技术有限公司 鼠尾草花提取物的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556969B1 (fr) * 1983-12-27 1986-04-25 Oreal Composition cosmetique ou pharmaceutique a base d'extraits vegetaux ayant une action sur la fragilite capillaire
FR2604361B1 (fr) * 1986-09-30 1989-01-06 Ortiz Georges Baume destine au traitement des varices et des maladies de la circulation sanguine
EP0454097B1 (en) * 1990-04-25 1994-09-28 Norac Technologies Inc. Labiatae derived antioxidant composition

Also Published As

Publication number Publication date
WO1994017814A1 (de) 1994-08-18
DE4303823C2 (de) 1997-08-07
AU6001894A (en) 1994-08-29
GR3030869T3 (en) 1999-11-30
HK1011937A1 (en) 1999-07-23
CN1117712A (zh) 1996-02-28
DE59408250D1 (de) 1999-06-17
EP0683672A1 (de) 1995-11-29
JP3390443B2 (ja) 2003-03-24
US5660831A (en) 1997-08-26
JPH08508243A (ja) 1996-09-03
DE4303823A1 (de) 1994-08-11
ATE179893T1 (de) 1999-05-15
EP0683672B1 (de) 1999-05-12
DK0683672T3 (da) 1999-11-01
CN1056285C (zh) 2000-09-13

Similar Documents

Publication Publication Date Title
AR010385A1 (es) Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto.
BR9406513A (pt) Composição farmaceutica disponivel em água e processo para preparar composição
CA2088343A1 (en) Stable fibrinogen solution
CA2067381A1 (en) Treatment of hiv infections and compounds useful therein
ES2133537T3 (es) Extracto de flores de salvia officinalis, procedimiento para su preparacion y su uso.
NO864147L (no) Fremgangsmaate for fremstilling av alginater(polyuronider) med endrede fysikalske egenskaper.
EP1450771A4 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF TUMORS AND LESIONS OF SKIN AND MICE AND THESE METHOD AND KITS
TWI281862B (en) Use of plant extracts for treatment of acne and furuncle
DE3682811D1 (de) Pharmazeutische zusammensetzung zur heilung und verhuetung kardiovaskularer krankheiten und verfahren zu ihrer herstellung.
FR2731907B1 (fr) Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
HUT67321A (en) Transdermal preparations containing lanolin derivatives as penetration- promoting agent
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
KR910000146A (ko) 동결- 건조된 조성물 및 그 제조 방법
UY26514A1 (es) " composición para el tratamiento de tejidos danados".
CA2369275A1 (en) Process for the preparation of autocrosslinked compounds of hyaluronic acid and the derivatives thereof by the supercritical antisolvent technique
DE69622704D1 (de) Pharmazeutische zusammensetzungen zur behandlung von alkoholsucht
EP0030977B1 (en) Prophylactic and curative medicine for cirrhotic liver
BR0303384A (pt) Citalopram e seus usos no tratamento de pressão sanguìnea elevada
JPH0296532A (ja) トベラ科植物からの水溶性抽出物より成る肝臓疾患治療剤
马元璋 et al. TRAITEMENT DES FRACTURES DE L'OLECRANE PAR SUTURE PERCUTANEE
ATE79760T1 (de) Verfahren und zubereitungen fuer die behandlung von niddm.
AU3248395A (en) Ring d-modified gibberellin compounds, and preparation and use thereof
IT1268454B1 (it) Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.
KR950016768A (ko) 손상된 뼈(骨)의 회복을 촉진하는 약제의 조성물 그 제조방법
DE3876448D1 (de) Verwendung eines tripeptids zur herstellung einer pharmazeutischen zusammensetzung sowie eine pharmazeutische zusammensetzung und methode.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 683672

Country of ref document: ES